The Motley Fool··Prosper Junior BakinyNovartis Edges Out Merck as Superior Pharma Dividend Play
Novartis offers better dividend yields and diversification than Merck, with stronger long-term prospects despite both beating the S&P 500.
MRKNVSdividend stocksdividend yield